Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.

Abstract

Japanese Ministry of Health, Labour and Welfare.

Full Text

• DOI - Lancet (DOI)
• Swets Information Services - full-text online
• OhioLINK Electronic Journal Center - full-text online
• Elsevier Science - full-text online
• EBSCO - full-text online

Subjects

• Anti-Inflammatory Agents
• Aspirin
• Child, Preschool
• Coronary Artery Disease
• Coronary Vessel Anomalies
• Drug Therapy, Combination
• Female
• Humans
• Immunoglobulins
• Infant
• Male
• Mucocutaneous Lymph Node Syndrome
• Prednisolone
• Prospective Studies

Authors

• Tohru Kobayashi
• Tsutomu Saji
• Tetsuya Otani
• Kazuo Takeuchi
• Tetsuya Nakamura
• Hirokazu Arakawa
• Taichi Kato
• Toshiro Hara
• Kenji Hamaoka
• Shunichi Ogawa
• Masaru Miura
• Yuichi Nomura
• Shigeto Fuse
• Fukiko Ichida
• Mitsuru Seki
• Ryuji Fukazawa
• Chitose Ogawa
• Kenji Furuno

Publication date

2012-04-30

Journal

Journal topics

• Medicine

Language

Eng.

Copyright

Lancet

Department of Pediatrics, Gunma University Graduate School of Medicine, Gunma, Japan. torukoba [at] nifty.com

Release reference

Lancet. 2012 Apr;379(9826):1613-20

Related books

• Books of Anti-Inflammatory Agents
• Books of Aspirin
• Books of Coronary Artery Disease
• Books of Coronary Vessel Anomalies
• Books of Drug Therapy, Combination
• Books of Immunoglobulins
• Books of Medicine
• Books of Mucocutaneous Lymph Node Syndrome
• Books of Prednisolone
• Books of Prospective Studies